Charline Coquerel

Sr. Director, coms & public affairs rare diseases @Novonordisk. "Moins ils ont d'idées à exprimer, plus ils parlent."

[Charline Coquerel @Cha3C]

@GeneveAeroport jamais vu ça! en transit via GVA: aller - on ne peut pas acheter de produits car on va en France retour - on ne peut pas acheter car vol intérieur Suisse. Franchement, service commercial à revoir. Pas d info!!

[Novo Nordisk @novonordisk]

No family should wait 6 years to receive a diagnosis. With the @Screen4Care initiative we aim to tackle the major hurdle for #raredisease patients – the lengthy and convoluted diagnosis journey. Learn more below 👇

[Novo Nordisk @novonordisk]

#PRESS: Novo Nordisk receives positive opinion from the European regulatory authorities for the treatment of adult growth hormone deficiency

[Charline Coquerel @Cha3C]

https://t.co/tD8jnK1V2i

[Charline Coquerel @Cha3C]

https://t.co/whhmw5l14V connects people with diabetes in the 🇺🇸🇺🇸 to the insulin access and affordability options that match their unique circumstances. 👇🏻 https://t.co/JxoYa1Q0yf

[Charline Coquerel @Cha3C]

📣 US network : The Obesity Action Coalition needs you 👇🏻 https://t.co/gqDc1Q1HGX

[Charline Coquerel @Cha3C]

Join Sara Mobäck, @kiffty and myself for an engaging & dynamic dialogue #GPC2020 #worldpatientsafetyday
Free registration https://t.co/4UEMZgZzjW

[Charline Coquerel @Cha3C]

My take so far from Sarah Le Brocq Obesity UK
« Positive langage brings positive outcomes »
Join the conversation 👇🏻 https://t.co/cqoY7fpqMB

[Charline Coquerel @Cha3C]

It starts in 5 min👇🏻👇🏻Join ECPO Patients

#PeopleFirst #obesity #ECOICO2020 https://t.co/Rn1CLSRzwu

[Charline Coquerel @Cha3C]

"Patient preference (PP) information is currently not routinely considered one of the requirements for decision-making."
let´s change this...

#patientengagement #patientpreference #patientcentricity https://t.co/98jxQ20vUu

[Charline Coquerel @Cha3C]

Before you rush into developing your next health app... read this :-)

"Adherence differed slightly across baseline patient characteristics, with higher adherence in older patients as well as those with less disease activity. The…https://t.co/FJqwZZEgvc https://t.co/qQDJmXHpsp

[Charline Coquerel @Cha3C]

"The literature shows that engaging patients in planning and improvement activities yield many benefits to patients and health service organizations. [...] these benefits come from authentic collaboration and partnerships, whereby…https://t.co/tq6XSeN4hG https://t.co/jxBG6n608S

[Charline Coquerel @Cha3C]

Germany recognised Obesity as a disease.
Well done and seize the day Andreas Herdt and Melanie Bahlke

#peoplefirst #obesity https://t.co/NTLXNLLGrz

[Charline Coquerel @Cha3C]

I am sure you have 2mins to read this 👇🏻
#obesity #health https://t.co/p5DcNNu74P

[Charline Coquerel @Cha3C]

What are you doing on Monday 29 June at 14:30 CEST ?
Join Camilla Sylvest and Cristina Petrut here on LinkedIn for a live meeting.

#novonordisk #patientengagement #diabetes #covid19 https://t.co/vyeuSzDPVv

[Paroles d'auteurs @Paroles_auteurs]

"Toute réussite nous attire un ennemi. C'est la médiocrité qui entraîne la popularité."
Oscar Wilde

[ECPO @ECPObesity]

Here’s a new ECPO infographic outlining the most important points from yesterday’s @POLITICOEurope article!

[Charline Coquerel @Cha3C]

Post COVID-19 in 🇪🇺 an opportunity for reality check and transformation
#patientexperience #healthcare https://t.co/h0sJT6ZTT4

[Charline Coquerel @Cha3C]

Sign up now 👇🏻
#patientcentricity #patientexperience #patientadvocacy https://t.co/KLDjM33ibU

[Charline Coquerel @Cha3C]

You go girl 👊🏻👊🏻 https://t.co/nrvSjRNsUZ